'Hepatic steatosis' diaporamas de présentation

Review of HIV Therapy

Review of HIV Therapy. Ronald D. Wilcox MD FAAP Project Director / Principal Investigator, DAETC Assistant Professor of Internal Medicine and Pediatrics, LSUHSC. Disclaimer. The speaker receives funding for research from the following companies: Tibotec Pfizer Boeringer-Ingelheim

901 views • 71 slides

NAFLD

NAFLD. 1)Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults Dr.mousavi -Abadan- Khordad 1397.

934 views • 61 slides

Medical Nutrition Therapy for Liver, Biliary System, and Exocrine Pancreas Disorders

Medical Nutrition Therapy for Liver, Biliary System, and Exocrine Pancreas Disorders. Relationship of Organs of the Upper Abdomen. A, Liver (retracted upward); B, gallbladder; C, esophageal opening of the stomach; D, stomach (shown in dotted outline); E, common

963 views • 42 slides

Nonalcoholic Fatty Liver Disease Case Discussion

Nonalcoholic Fatty Liver Disease Case Discussion. Hengameh Abdi , MD Endocrine Research Center Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences 21 July 2016. Case 1. Case 1.

1.16k views • 37 slides

NAFLD

NAFLD. Dr Allister J Grant Consultant Hepatologist. How common is NAFLD?. The most common cause of abnormal liver function tests in the United States. Estimated 30.1 million with NAFLD and 8.6 million with NASH Affects 10-24% of the population 58-74% of the obese population

1.2k views • 31 slides

??? ???? ?????? ??????

??? ???? ?????? ??????. PHARMACOTHERAPY FOR NASH: CURRENT AND EMERGING. Prof. Dr. Amr Abd Elmoty. Hepatology unit- 18/10/2018.

308 views • 29 slides

EASL NAFLD Summit 2019

EASL NAFLD Summit 2019. Abstract highlights. About these slides. These slides provide highlights of new data presented at the EASL NAFLD Summit 2019 Please feel free to use, adapt and share these slides for your own personal use; however, please acknowledge EASL as the source

283 views • 25 slides

Care of the Treatment-naive Patient With HCV/HIV Coinfection

359 views • 20 slides

Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease. s_khalilzadeh. A Novel Cardiometabolic Risk Factor for Type 2 Diabetes. NAFLD and T2DM. NAFLD is closely associated with features of the metabolic syndrome and is regarded as the hepatic manifestation

988 views • 20 slides

Nonalcoholic fatty liver disease (NAFLD)

Nonalcoholic fatty liver disease (NAFLD). the presence of hepatic steatosis When no other causes for secondary hepatic fat accumulation NAFLD may progress to cirrhosis and is likely an important cause of cryptogenic cirrhosis. NAFL versus NASH.

783 views • 13 slides

Symptoms Of Fatty Liver (Hepatic Steatosis)

Fatty Liver is also known as Hepatic Steatosis. It is caused by the excess build up of fat in the liver. Know about the common symptoms of Fatty Liver. DDRC SRL medical testing laboratory provides excellent diagnostic lab facilities for liver diseases.

54 views • 1 slides